Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT is a research paper published in Health Technology Assessment (2020). On theSindex it has a DataRank of 2.5. It has been cited 89 times, with 64 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.675
From this paper's citation signal
Citation Network Contribution
1.8
From 42 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 64 citers.
Cancer Research UK
Grant: 27047
National Institute for Health Research (NIHR)
Grant: 10/57/55
Cancer Research UK
Medical Research Council
National Institute for Health Research (NIHR)
American Cancer Society
US National Cancer Institute
MeSH Terms
Keywords
Additional file 1 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 1 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 2 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 2 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 3 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 3 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 4 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 4 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 5 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 5 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 6 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 6 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 7 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 7 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 8 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 8 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 9 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 9 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 10 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020
Additional file 10 of Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004–2020